Factors that may play a role in these disappointing results regarding preservation of renal function include the global burden of atherosclerosis, renal parenchymal and small vessel arterial disease, ...

Recent trials of percutaneous revascularization for the treatment of renal artery stenosis have been disappointing. In many cases, essential hypertension coexists with the presence of renal artery ...

THE appreciation of renal-artery lesions as a cause of systemic hypertension began with the work of Goldblatt et al. 1 in 1934. This experimental finding was immediately implicated in human ...

We present a case, who after 15 years of renal transplantation developed severe deterioration of her hypertension without alteration in renal function. Colour Doppler sonography revealed a 90% ...

The hypertensive index may predict the likelihood of kidney function improvement following renal revascularization for renal artery stenosis. The hypertensive index may distinguish which patients with ...

Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment ...

Approval Supported by the HERCULES Study, Which Demonstrated that Renal Stenting with RX Herculink Elite® is Safe and Significantly Reduces Blood Pressure at Nine Months ABBOTT PARK, Ill., Aug. 10, ...

Medtronic (NYSE: MDT) today announced new long-term results from its final report of the SPYRAL HTN-ON MED trial.

The Paradise ultrasound renal denervation system got backing from the FDA's Circulatory System Devices Panel as a possible treatment for hypertension, as manufacturer ReCor continues to hope for ...

To the Editor: In their article on renal arteriography, which appeared in the March 26 issue of the Journal, Vertes et al. conclude that "hypertension due to renal ischemia, caused by stenosis of one ...